trending Market Intelligence /marketintelligence/en/news-insights/trending/eiCVla5ux4OS1zivXzCVxQ2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

Abcam adds director


COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021


Climate Credit Analytics: Linking climate scenarios to financial impacts


Global M&A Infographic Q1 2021


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Abcam adds director

Abcam Plc appointed Giles Kerr to the board as a nonexecutive director, effective Dec. 12.

Kerris is a nonexecutive director at Arix Bioscience PLC, Isis Innovation Ltd. and Oxford Sciences Innovation.

Cambridge, U.K.-based Abcam produces and distributes research-grade antibodies and associated protein research tools worldwide.